Literature DB >> 21193185

Sexual dysfunction in patients with polycystic ovary syndrome: clinical and hormonal correlations.

Andre Barciela Veras1, Ricardo V Bruno, Marcio Augusto P de Avila, Antonio E Nardi.   

Abstract

OBJECTIVE: The aim of this study was to investigate the sexual function of patients with polycystic ovary syndrome (PCOS), including the clinical and hormonal characteristics potentially related to sexual dysfunction, in an endocrinology and gynecology ambulatory.
METHODOLOGY: Women in ambulatory accompaniment for PCOS (N = 88) were sequentially evaluated by means of the Arizona Sexual Experience Scale (ASEX) and the application of structured diagnostic interview Mini International Neuropsychiatric Interview (version 4.4) for the identification of mood disorders. The clinical and laboratorial parameters were examined using the patient's medical records.
RESULTS: The incidence of sexual dysfunction was verified (13.3%), and it was observed that the average (SD) ASEX score of 14.4 (3.7) was comparable with that of the population with no medical problems. There is a negative correlation between the scores of ASEX and the levels of total testosterone (-0.360), luteinizing hormone (-0.397), and dehydroepiandrosterone sulfate (-0.723).
CONCLUSION: The main factors of preservation of the sexual function in our sample were identified as the low average age of the patients in treatment and the hyperandrogenism habitually found as a consequence of the physiopathology of PCOS.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21193185     DOI: 10.1016/j.comppsych.2010.10.013

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  8 in total

1.  Sexual function and hormonal profiles in women with and without polycystic ovary syndrome: a population-based study.

Authors:  M Noroozzadeh; F Ramezani Tehrani; S Sedigh Mobarakabadi; M Farahmand; M Rostami Dovom
Journal:  Int J Impot Res       Date:  2016-09-22       Impact factor: 2.896

2.  Health-related quality of life questionnaire for polycystic ovary syndrome (PCOSQ-50): development and psychometric properties.

Authors:  Fatemeh Nasiri-Amiri; Fahimeh Ramezani Tehrani; Masoumeh Simbar; Ali Montazeri; Reza Ali Mohammadpour
Journal:  Qual Life Res       Date:  2016-01-27       Impact factor: 4.147

3.  Sexual dysfunction in patients with polycystic ovary syndrome and its affected domains.

Authors:  Tahereh Eftekhar; Farnaz Sohrabvand; Neda Zabandan; Mamak Shariat; Fedyeh Haghollahi; Akram Ghahghaei-Nezamabadi
Journal:  Iran J Reprod Med       Date:  2014-08

4.  Sexuality and psychological well-being in different polycystic ovary syndrome phenotypes compared with healthy controls: a cross-sectional study.

Authors:  Fatemeh Bahadori; Shahideh Jahanian Sadatmahalleh; Ali Montazeri; Malihe Nasiri
Journal:  BMC Womens Health       Date:  2022-09-25       Impact factor: 2.742

5.  Psychological disturbances and quality of life in obese and infertile women and men.

Authors:  Piotr Kocełak; Jerzy Chudek; Beata Naworska; Monika Bąk-Sosnowska; Barbara Kotlarz; Monika Mazurek; Paweł Madej; Violetta Skrzypulec-Plinta; Piotr Skałba; Magdalena Olszanecka-Glinianowicz
Journal:  Int J Endocrinol       Date:  2012-07-16       Impact factor: 3.257

6.  Female sexual dysfunction in patients with substance-related disorders.

Authors:  Alessandra Diehl; Rosiane Lopes da Silva; Ronaldo Laranjeira
Journal:  Clinics (Sao Paulo)       Date:  2013       Impact factor: 2.365

7.  Sexual Function in Chinese Women with Polycystic Ovary Syndrome and Correlation with Clinical and Biochemical Characteristics.

Authors:  Xuanxuan Tian; Xiangyan Ruan; Juan Du; Juan Wang; Dongmei Yin; Jiaojiao Cheng; Rui Ju; Alfred O Mueck
Journal:  Reprod Sci       Date:  2021-06-02       Impact factor: 2.924

8.  Lower sexual satisfaction in women with polycystic ovary syndrome and metabolic syndrome.

Authors:  Małgorzata Kałużna; Agnieszka Nomejko; Aleksandra Słowińska; Katarzyna Wachowiak-Ochmańska; Katarzyna Pikosz; Katarzyna Ziemnicka; Marek Ruchała
Journal:  Endocr Connect       Date:  2021-08-30       Impact factor: 3.335

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.